News Search Results
Oct 24, 2025, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
strong recommendation and high certainty of evidence that can be used with or without topicals, according to guidelines published by the American Academy of Dermatology (AAD),** which are used as a key consideration for dermatologists and managed care providers. Lilly continues to
More news about: Eli Lilly and Company
Oct 24, 2025, 06:45 ET Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
36-week results from the BRAVE-AA-PEDS trial previously presented at the 2025 American Academy of Dermatology (AAD) annual meeting in March. "For nearly half of the people with severe alopecia areata, the disease starts before
More news about: Eli Lilly and Company
Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
Cutaneous Lymphoma Foundation and a member of the U.S. Cutaneous Lymphoma Consortium. She is an editorial reviewer for the Journal of the American Academy of Dermatology. Youn Kim, MD
More news about: Soligenix
Oct 07, 2025, 17:31 ET AHR Agonists Market Trends Signal Promising Growth in Immunology and Dermatology Therapeutics | DelveInsight
the Phase III ADORING 3 open-label extension study of VTAMA cream, 1%, in patients aged 2 and older with atopic dermatitis at the American Academy of Dermatology (AAD) Annual Meeting. The data showed that patients who achieved treatment success maintained mild disease activity over an average 80-day
More news about: DelveInsight Business Research, LLP
Oct 01, 2025, 08:35 ET skinbetter science® Launches Mystro Revive Renewing Serum for Perimenopausal and Menopausal Skin
According to the American Academy of Dermatology,
More news about: skinbetter science
Sep 22, 2025, 17:31 ET Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along with rising prevalence | DelveInsight
clinical trials (TRuE-PN1 and TRuE-PN2 studies) evaluating ruxolitinib cream 1.5% (OPZELURA) in patients with prurigo nodularis at the 2025 American Academy of Dermatology (AAD) Annual Meeting.According to the Q2 2025 Kyowa Kirin corporate presentation, Phase III completion for rocatinlimab
More news about: DelveInsight Business Research, LLP
Sep 18, 2025, 09:00 ET LA ROCHE-POSAY TEAMS UP WITH GLOBAL GAMING PHENOMENON NINJA FOR GAMING FOR CAUSE, A 24-HOUR LIVESTREAM CHARITY EVENT TO CHAMPION SKIN CANCER AWARENESS AND PREVENTION
[email protected] 1 Holman, Dawn M et al. "Patterns of sunscreen use on the face and other exposed skin among US adults." Journal of the American Academy of Dermatology vol. 73,1 (2015): 83-92.e1. doi:10.1016/j.jaad.2015.02.11122 Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella
More news about: La Roche-Posay
Sep 17, 2025, 08:00 ET Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of novel targeted oral peptide for treatment of plaque psoriasis
presented at the American Academy of Dermatology 2025 Congress.3"The long-term data from ICONIC-LEAD continue to demonstrate the potential of icotrokinra to address
More news about: Johnson & Johnson
Aug 14, 2025, 17:31 ET Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight
Therapeutics announced the presentation of two head-to-head preclinical studies of its oral psoriasis treatment candidate, SFA-002, at the American Academy of Dermatology Annual Meeting in Orlando, Florida.In March 2025, SFA Therapeutics
More news about: DelveInsight Business Research, LLP
Aug 04, 2025, 08:54 ET WellAve Dermatology Celebrates 1,200 Mohs Surgeries at Frederick, Maryland Surgery Center
ability to serve the community," said Dr. Allan Harrington, Founder of WellAve Dermatology and Fellow of the American Academy of Dermatology. "Together, we offer a Mohs surgical team that is unmatched anywhere in the state. Our patients deserve the best, and now they have it—right
More news about: WellAve Dermatology
Jul 30, 2025, 09:00 ET PHYSICIANS FORMULA ANNOUNCES 2025 PHYSICIANS COALITION PARTNERS
and owner of OSVI Dermatology and Surgical institute in Los Angeles, CA. Dr. Shokeen is a member of the American Academy of Dermatology (AAD), American Society of Dermatologic Surgery (ASDS), and Women's Dermatology Society (WDS). She has authored multiple publications in
More news about: Physicians Formula
Jul 29, 2025, 08:31 ET CielementsMD® Named Best Skin Care Innovation by 2025 Marie Claire Skin & Hair Awards
clinical study in the Journal of the American Academy of Dermatology (JAAD), marking the first-ever in-human clinical trial to demonstrate that a CBD-based topical can reduce ultraviolet A UVA–induced DNA
More news about: CielementsMD
Jul 21, 2025, 17:31 ET Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight
open-label extensions, investigating BIMZELX in adults with moderate-to-severe plaque psoriasis, were presented as six posters at the 2025 American Academy of Dermatology (AAD) annual meeting in Orlando, Florida. Dual inhibition with bimekizumab-bkzx demonstrated high efficacy
More news about: DelveInsight Business Research, LLP
Jul 21, 2025, 08:00 ET Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis
presented as a late-breaking abstract at the 2025 American Academy of Dermatology (AAD) Annual Meeting, that showed icotrokinra successfully met the co-primary endpoints of Investigator's Global Assessment (IGA)d
More news about: Johnson & Johnson
Jul 09, 2025, 09:01 ET Eirion Therapeutics to Present at the 2025 American Academy of Dermatology Innovation Academy Meeting
biopharmaceutical company focused on developing innovative aesthetic prescription products, today announced that the company will present at the 2025 American Academy of Dermatology Innovation Academy meeting taking place July 10 – 13, 2025, in Chicago, Illinois.
More news about: Eirion Therapeutics, Inc.
Jul 07, 2025, 12:37 ET Protect Skin from the Sun
reduced markers of UV damage at the cellular level. This study reinforced previous and similar findings published in the "Journal of the American Academy of Dermatology." Grapes are also a hydrating food with 82% water content; hydration is essential to healthy skin. Along with snacking on fresh,
More news about: Family Features Editorial Syndicate
Jul 07, 2025, 09:00 ET U.S. Dermatology Partners Opens New Location in Richmond, Virginia Suburb
community he knows and loves." Dr. Kennedy is board certified by the American Board of Dermatology and a longstanding member of the American Academy of Dermatology. Having served in the Air Force for 10 years, Dr. Kennedy held positions as Chief Dermatologist at Andrews AFB, Maryland
More news about: U.S. Dermatology Partners
Jun 24, 2025, 22:00 ET DR.CI:LABO™於2025年IMCAS亞洲大會上發布新數據
assessment of skin care formulations containing trisodium ascorbyl6-palmitate 2-phosphate (APPS) for pre-aging skin, Poster number 61671, American Academy of Dermatology Annual Meeting, 7-11 March 2025, Orlando, Florida
More news about: DR.CI:LABO™
Jun 19, 2025, 15:00 ET JAAD IMPACT FACTOR RANKS NO. 1 AMONG DERMATOLOGY JOURNALS
Ill., June 19, 2025 /PRNewswire/ -- The Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field for the sixth straight year, according to the 2024 journal impact factor (JIF) rankings
More news about: American Academy of Dermatology
Jun 19, 2025, 08:47 ET Lavior Launches on Target.com with Breakthrough Botanical-Based Multipurpose Gel
improve lives through innovation rooted in nature." A Modern Healing Solution Backed by ScienceAccording to the American Academy of Dermatology, over 40 million Americans treat minor wounds at home annually, yet many still rely on outdated ointments that contain petroleum or antibiotics.
More news about: Lavior
May 27, 2025, 13:08 ET Tareen Dermatology welcomes Dr. Elisabeth Hurliman, MD, PhD
American College of Mohs Surgery, the American Society of Dermatologic Surgery, the American Society for Laser Medicine and Surgery, and the American Academy of Dermatology. Dr. Hurliman's expertise and clinical interests include Mohs surgery and reconstructions, surgical dermatology, and dermatologic oncology.
More news about: Tareen Dermatology
May 27, 2025, 10:46 ET Think That DIY Acne Trick Is Helping? Here's What Dermatologists Want You to Know
Acne Resource Center About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
May 22, 2025, 08:00 ET MINO Labs Publishes First-Ever Human Clinical Trial Demonstrating Protective Benefits of CBD Cream Against UVA-Induced Skin Damage--Offering New Hope for Fighting Skin Cancer and Photoaging
privately held specialty pharmaceutical company, is proud to announce the publication of a groundbreaking clinical study in the Journal of the American Academy of Dermatology (JAAD), highlighting the protective benefits of its patented CannaXR™ (extended release) cannabidiol (CBD) cream:
More news about: MINO Labs
May 20, 2025, 11:22 ET AAD Survey: Half of Gen Z Got Sunburned in 2024--And Many Still Don't Know the Risks
ROSEMONT, Ill., May 20, 2025 /PRNewswire/ -- A recent American Academy of Dermatology survey of more than 1,000 U.S. adults reveals a troubling reality—many Americans are unwittingly increasing their skin cancer risk due
More news about: American Academy of Dermatology
May 13, 2025, 16:49 ET Baricitinibe, da Lilly, proporcionou altas taxas de crescimento capilar em adolescentes com alopecia areata grave, aponta estudo
regrowth in adolescents with severe alopecia areata: 36-week efficacy and safety results from a Phase 3 randomized, controlled trial. American Academy of Dermatology Annual Meeting. March 7-11, 20252 Alopecia areata. National Alopecia Areata Foundation
More news about: Eli Lilly do Brasil